These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22629296)

  • 1. A pilot trial assessing urinary gene expression profiling with an mRNA array for diabetic nephropathy.
    Zheng M; Lv LL; Cao YH; Liu H; Ni J; Dai HY; Liu D; Lei XD; Liu BC
    PLoS One; 2012; 7(5):e34824. PubMed ID: 22629296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary mRNA markers of epithelial-mesenchymal transition correlate with progression of diabetic nephropathy.
    Zheng M; Lv LL; Cao YH; Zhang JD; Wu M; Ma KL; Phillips AO; Liu BC
    Clin Endocrinol (Oxf); 2012 May; 76(5):657-64. PubMed ID: 21824169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CDH2 and MCP-1 mRNAs of blood extracellular vesicles in predicting early-stage diabetic nephropathy.
    Dehghanbanadaki H; Forouzanfar K; Kakaei A; Zeidi S; Salehi N; Arjmand B; Razi F; Hashemi E
    PLoS One; 2022; 17(4):e0265619. PubMed ID: 35363774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy.
    Zheng M; Lv LL; Ni J; Ni HF; Li Q; Ma KL; Liu BC
    PLoS One; 2011; 6(5):e20431. PubMed ID: 21655212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary podocyte-associated mRNA profile in Egyptian patients with diabetic nephropathy.
    Fayed A; Rahman Tohamy IA; Kahla H; Elsayed NM; El Ansary M; Saadi G
    Diabetes Metab Syndr; 2019; 13(5):2849-2854. PubMed ID: 31425946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-2-microglobulin (B2M) expression in the urinary sediment correlates with clinical markers of kidney disease in patients with type 1 diabetes.
    Monteiro MB; Thieme K; Santos-Bezerra DP; Queiroz MS; Woronik V; Passarelli M; Machado UF; Giannella-Neto D; Oliveira-Souza M; Corrêa-Giannella ML
    Metabolism; 2016 Jun; 65(6):816-24. PubMed ID: 27173460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.
    Lioudaki E; Stylianou KG; Petrakis I; Kokologiannakis G; Passam A; Mikhailidis DP; Daphnis EK; Ganotakis ES
    Nephron; 2015; 131(1):34-42. PubMed ID: 26340089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Exosomal mRNA of WT1 as Diagnostic and Prognostic Biomarker for Diabetic Nephropathy.
    Abe H; Sakurai A; Ono H; Hayashi S; Yoshimoto S; Ochi A; Ueda S; Nishimura K; Shibata E; Tamaki M; Kishi F; Kishi S; Murakami T; Nagai K; Doi T
    J Med Invest; 2018; 65(3.4):208-215. PubMed ID: 30282862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WT1 and ACE mRNAs of blood extracellular vesicle as biomarkers of diabetic nephropathy.
    Hashemi E; Dehghanbanadaki H; Baharanchi AA; Forouzanfar K; Kakaei A; Mohammadi SM; Zeidi S; Razi F
    J Transl Med; 2021 Jul; 19(1):299. PubMed ID: 34246281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics-based discovery of the urinary BBOX1 mRNA as a potential biomarker of diabetic kidney disease.
    Zhou LT; Lv LL; Qiu S; Yin Q; Li ZL; Tang TT; Ni LH; Feng Y; Wang B; Ma KL; Liu BC
    J Transl Med; 2019 Feb; 17(1):59. PubMed ID: 30819181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioredoxin interacting protein expression in the urinary sediment associates with renal function decline in type 1 diabetes.
    Monteiro MB; Santos-Bezerra DP; Thieme K; Admoni SN; Perez RV; Machado CG; Queiroz MS; Nery M; Oliveira-Souza M; Woronik V; Passarelli M; Giannella-Neto D; Machado UF; Corrêa-Giannella ML
    Free Radic Res; 2016; 50(1):101-10. PubMed ID: 26480949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy.
    Wang G; Lai FM; Lai KB; Chow KM; Li KT; Szeto CC
    Nephron Clin Pract; 2007; 106(4):c169-79. PubMed ID: 17596726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin Receptor Substrate 2 mRNA Expression in Urinary Sediment Cells as a Diagnostic Marker of Nephropathy in Diabetic Patients.
    Salimi M; Sarrafzadeh Zargar S
    Iran J Kidney Dis; 2018 May; 12(3):142-149. PubMed ID: 29891743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of circulating lncRNA expression profiles in patients with diabetes mellitus and diabetic nephropathy: Differential expression profile of circulating lncRNA
.
    Yang Y; Lv X; Fan Q; Wang X; Xu L; Lu X; Chen T
    Clin Nephrol; 2019 Jul; 92(1):25-35. PubMed ID: 31079598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary small extracellular vesicles derived CCL21 mRNA as biomarker linked with pathogenesis for diabetic nephropathy.
    Feng Y; Zhong X; Ni HF; Wang C; Tang TT; Wang LT; Song KY; Tang RN; Liu H; Liu BC; Lv LL
    J Transl Med; 2021 Aug; 19(1):355. PubMed ID: 34404433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S; Matboli M; Bekhet MM
    Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
    El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
    IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary sediment CCL5 messenger RNA as a potential prognostic biomarker of diabetic nephropathy.
    Feng ST; Yang Y; Yang JF; Gao YM; Cao JY; Li ZL; Tang TT; Lv LL; Wang B; Wen Y; Sun L; Xing GL; Liu BC
    Clin Kidney J; 2022 Mar; 15(3):534-544. PubMed ID: 35211307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Value of Urinary Exosome-Derived let-7c-5p in the Diagnosis and Progression of Type II Diabetic Nephropathy.
    Li W; Yang S; Qiao R; Zhang J
    Clin Lab; 2018 May; 64(5):709-718. PubMed ID: 29739042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.